Trials / Recruiting
RecruitingNCT06780917
Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Centre for Addiction and Mental Health · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to validate the Creyos online cognitive assessment platform in individuals with mild cognitive impairment, or remitted major depressive disorder. The main objectives of this research are: 1. To confirm the feasibility of administering the Creyos cognitive battery to older adults with Mild Cognitive Impairment MCI) or Major Depressive Disorder in remission (rMDD). 2. To determine whether the Creyos battery can detect changes in cognition that are predictive of changes on paper-and-pencil neuropsychological testing ("gold standard") over up to five years. Participants will complete both in-person neuropsychological testing yearly as well as the Creyos online battery quarterly for up to 5 years, to allow us to compare performance on these two batteries over time.
Conditions
- Mild Cognitive Impairment (MCI)
- Major Depressive Disorder, Remitted
- Healthy Controls Group - Age and Sex-matched
Timeline
- Start date
- 2025-01-13
- Primary completion
- 2029-01-01
- Completion
- 2029-01-01
- First posted
- 2025-01-17
- Last updated
- 2026-03-10
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06780917. Inclusion in this directory is not an endorsement.